195 related articles for article (PubMed ID: 37941134)
1. TREM2 mediates MHCII-associated CD4+ T-cell response against gliomas.
Zheng J; Wang L; Zhao S; Zhang W; Chang Y; Bosco DB; Huang T; Dheer A; Gao S; Xu S; Ayasoufi K; Al-Kharboosh R; Qi F; Xie M; Johnson AJ; Dong H; Quiñones-Hinojosa A; Wu LJ
Neuro Oncol; 2024 May; 26(5):811-825. PubMed ID: 37941134
[TBL] [Abstract][Full Text] [Related]
2. TREM2 mediates MHCII-associated CD4
Zheng J; Wang L; Zhao S; Zhang W; Chang Y; Dheer A; Gao S; Xu S; Ayasoufi K; Al-Kharboosh R; Xie M; Johnson AJ; Dong H; Quiñones-Hinojosa A; Wu LJ
bioRxiv; 2023 Apr; ():. PubMed ID: 37066234
[TBL] [Abstract][Full Text] [Related]
3. Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma.
Peshoff MM; Gupta P; Oberai S; Trivedi R; Katayama H; Chakrapani P; Dang M; Migliozzi S; Gumin J; Kadri DB; Lin JK; Milam NK; Maynard ME; Vaillant BD; Parker-Kerrigan B; Lang FF; Huse JT; Iavarone A; Wang L; Clise-Dwyer K; Bhat KP
Neuro Oncol; 2024 May; 26(5):826-839. PubMed ID: 38237157
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of trem2 promotes proinflammatory microglia and inhibits glioma progression via the JAK2/STAT3 and NF-κB pathways.
Yan Y; Bai S; Han H; Dai J; Niu L; Wang H; Dong Q; Yin H; Yuan G; Pan Y
Cell Commun Signal; 2024 May; 22(1):272. PubMed ID: 38750472
[TBL] [Abstract][Full Text] [Related]
5. TREM2 promotes glioma progression and angiogenesis mediated by microglia/brain macrophages.
Chen X; Zhao Y; Huang Y; Zhu K; Zeng F; Zhao J; Zhang H; Zhu X; Kettenmann H; Xiang X
Glia; 2023 Nov; 71(11):2679-2695. PubMed ID: 37641212
[TBL] [Abstract][Full Text] [Related]
6. Distinct roles of TREM2 in central nervous system cancers and peripheral cancers.
Zhong J; Xing X; Gao Y; Pei L; Lu C; Sun H; Lai Y; Du K; Xiao F; Yang Y; Wang X; Shi Y; Bai F; Zhang N
Cancer Cell; 2024 Jun; 42(6):968-984.e9. PubMed ID: 38788719
[TBL] [Abstract][Full Text] [Related]
7. Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke.
Kawabori M; Kacimi R; Kauppinen T; Calosing C; Kim JY; Hsieh CL; Nakamura MC; Yenari MA
J Neurosci; 2015 Feb; 35(8):3384-96. PubMed ID: 25716838
[TBL] [Abstract][Full Text] [Related]
8.
Yu M; Chang Y; Zhai Y; Pang B; Wang P; Li G; Jiang T; Zeng F
Front Immunol; 2022; 13():1089266. PubMed ID: 36713360
[TBL] [Abstract][Full Text] [Related]
9. TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma.
Sun R; Han R; McCornack C; Khan S; Tabor GT; Chen Y; Hou J; Jiang H; Schoch KM; Mao DD; Cleary R; Yang A; Liu Q; Luo J; Petti A; Miller TM; Ulrich JD; Holtzman DM; Kim AH
Sci Adv; 2023 May; 9(19):eade3559. PubMed ID: 37172094
[TBL] [Abstract][Full Text] [Related]
10. Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease.
Melchior B; Garcia AE; Hsiung BK; Lo KM; Doose JM; Thrash JC; Stalder AK; Staufenbiel M; Neumann H; Carson MJ
ASN Neuro; 2010 Jul; 2(3):e00037. PubMed ID: 20640189
[TBL] [Abstract][Full Text] [Related]
11. Trem2 deficiency impairs recovery and phagocytosis and dysregulates myeloid gene expression during virus-induced demyelination.
Hwang M; Savarin C; Kim J; Powers J; Towne N; Oh H; Bergmann CC
J Neuroinflammation; 2022 Nov; 19(1):267. PubMed ID: 36333761
[TBL] [Abstract][Full Text] [Related]
12. Triggering receptor expressed on myeloid cells-2 expression in the brain is required for maximal phagocytic activity and improved neurological outcomes following experimental stroke.
Kurisu K; Zheng Z; Kim JY; Shi J; Kanoke A; Liu J; Hsieh CL; Yenari MA
J Cereb Blood Flow Metab; 2019 Oct; 39(10):1906-1918. PubMed ID: 30523715
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of HLA-II related to LAG-3
Guo W; Peng D; Liao Y; Lou L; Guo M; Li C; Yu W; Tian X; Wang G; Lv P; Zuo J; Shen H; Li Y
Cancer Sci; 2024 May; 115(5):1388-1404. PubMed ID: 38480275
[TBL] [Abstract][Full Text] [Related]
14. Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma.
Peshoff MM; Gupta P; Trivedi R; Oberai S; Chakrapani P; Dang M; Milam N; Maynard ME; Vaillant BD; Huse JT; Wang L; Clise-Dwyer K; Bhat KP
bioRxiv; 2023 Apr; ():. PubMed ID: 37066184
[TBL] [Abstract][Full Text] [Related]
15. CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia/macrophages.
Levy A; Blacher E; Vaknine H; Lund FE; Stein R; Mayo L
Neuro Oncol; 2012 Aug; 14(8):1037-49. PubMed ID: 22700727
[TBL] [Abstract][Full Text] [Related]
16. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
Verschuere T; Toelen J; Maes W; Poirier F; Boon L; Tousseyn T; Mathivet T; Gerhardt H; Mathieu V; Kiss R; Lefranc F; Van Gool SW; De Vleeschouwer S
Int J Cancer; 2014 Feb; 134(4):873-84. PubMed ID: 23929302
[TBL] [Abstract][Full Text] [Related]
17. Brain cancer induces systemic immunosuppression through release of non-steroid soluble mediators.
Ayasoufi K; Pfaller CK; Evgin L; Khadka RH; Tritz ZP; Goddery EN; Fain CE; Yokanovich LT; Himes BT; Jin F; Zheng J; Schuelke MR; Hansen MJ; Tung W; Parney IF; Pease LR; Vile RG; Johnson AJ
Brain; 2020 Dec; 143(12):3629-3652. PubMed ID: 33253355
[TBL] [Abstract][Full Text] [Related]
18. TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway.
Zheng H; Jia L; Liu CC; Rong Z; Zhong L; Yang L; Chen XF; Fryer JD; Wang X; Zhang YW; Xu H; Bu G
J Neurosci; 2017 Feb; 37(7):1772-1784. PubMed ID: 28077724
[TBL] [Abstract][Full Text] [Related]
19. Differential modulation of TREM2 protein during postnatal brain development in mice.
Chertoff M; Shrivastava K; Gonzalez B; Acarin L; Giménez-Llort L
PLoS One; 2013; 8(8):e72083. PubMed ID: 23977213
[TBL] [Abstract][Full Text] [Related]
20. High-salt diet downregulates TREM2 expression and blunts efferocytosis of macrophages after acute ischemic stroke.
Hu M; Lin Y; Men X; Wang S; Sun X; Zhu Q; Lu D; Liu S; Zhang B; Cai W; Lu Z
J Neuroinflammation; 2021 Apr; 18(1):90. PubMed ID: 33845849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
